This approach substantially inhibited tumor growth and prolonged survival, potentially owing to increased intratumoral IFNγ post-anti-PD-1 treatment that likely renders Tregs more susceptible to KTC1101's inhibitory effects [53]. Here, PDCD1 is linked to neoplasm.